This study looks at using testosterone replacement therapy (TRT) for men with low testosterone who are having major urologic surgery. Testosterone is a hormone that helps with muscle strength and bone health. The study wants to see if using TRT during the time around surgery (perioperative period) can help patients recover better, spend less time in the hospital, and have fewer problems after surgery. In this trial, some patients with low testosterone will receive testosterone shots, called testosterone cypionate, once a week for 3 months. This study will check if this treatment is safe and if it can be used in future surgical care.

• Duration: Treatment with testosterone lasts for 3 months.
• Visits Required: Regular weekly visits for testosterone shots.
• Risks: Potential side effects and risks from testosterone therapy.

If you are considering joining the study, make sure you are eligible and comfortable with the commitment and potential risks involved.